Condition
Advanced Pancreatic Cancer clinical trials and research
Research outlook What's coming for Pancreatic cancer: the next 6 months to 5 yearsAs of November 12, 2026, Find a Trial lists 9 Advanced Pancreatic Cancer clinical trials that are recruiting, at sites in 2 countries (most in China (8), France (1)). By phase: Phase 1/2 (3), Early Phase 1 (2), Phase 2 (2), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 9Clinical trials
- 2Countries
Newest Advanced Pancreatic Cancer clinical trials
All recruiting trials (9)
-
GKL-006 injections with nab-paclitaxel and gemcitabine for advanced pancreatic cancer
This study tests GKL-006 given with standard chemotherapy to see if it helps patients with unresectable or metastatic pancreatic ductal adenocarcinoma.
-
IBI343 with chemotherapy in advanced pancreatic cancer
This study tests whether IBI343 combined with chemotherapy is safe and can help people with advanced pancreatic cancer.
-
Claudin18.2-targeted activated dendritic cell plus CAR-T therapy for advanced pancreatic cancer
This trial will test whether combining Claudin18.2-targeted activated dendritic cells with Claudin18.2 CAR-T cells helps people with advanced pancreatic cancer whose tumors express Claudin18.2.
-
hV01 (IL-21–expressing oncolytic vaccinia) for advanced pancreatic cancer
This trial tests whether injections of hV01, a vaccinia virus engineered to deliver IL‑21, can help people with advanced pancreatic cancer whose tumors can be injected.
-
LM-108 with penpulimab plus albumin-bound paclitaxel and gemcitabine for advanced pancreatic cancer (Cohort C)
This study will test whether adding LM-108 to penpulimab with albumin-bound paclitaxel and gemcitabine helps people with advanced pancreatic cancer.
-
Evaluating NRT6008 for patients with advanced pancreatic cancer
This study is testing a new injection called NRT6008 to see if it is safe and effective for people with advanced pancreatic cancer that can't be removed by surgery.
-
Evaluating Pimicotinib with Chemotherapy for Advanced Pancreatic Cancer
This study is testing if a new drug called Pimicotinib, used with chemotherapy, can help people with advanced pancreatic cancer feel better and improve their treatment outcomes.
-
Personalized tumor vaccines combined with Pembrolizumab for advanced pancreatic cancer
This study is testing a personalized tumor vaccine with a cancer drug to see if it helps people with advanced pancreatic cancer whose previous treatments didn't work.
-
Molecular screening for advanced pancreatic cancer patients
This study is testing if analyzing tumor and blood samples from patients with advanced pancreatic cancer can help doctors choose the best personalized treatment options before they start their first round of therapy.
Related topics
Quick answers
How many Advanced Pancreatic Cancer clinical trials are recruiting right now?
9, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in China (8 trials), France (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 3, Early Phase 1: 2, Phase 2: 2, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.